Gates Package — page 751

Dr. Fauci ma 1.Z0V> 3 AM dential and may contain sensitive information. It should not be used by anyone who is not n error please inform the sender and delete it from your mailbox or any other storage AID) shall not accept liability for any statement made that are sender's own and not ives. Mike Poole @gatesfoundation.org> Subject: Re: on behalf of Dr. Fauci Thanks Pat, hi Cliff we were just on a call with Tony and Bill and they agreed that we should look at how we might coordinate our activities in the plasma trial space as we are working with the same consortium to see if recruitment of donors and the actual trial might be accelerated. As we're more focused on post-exposure prophylaxis and treatment of mild high risk cases to prevent progression there might be some synergies with your focus. I'm copying in my colleague Mike Poole who is leading our efforts and though we might get together on a call soon. Trevor Trevor Mundel, MD, PhD President, Global Health Program V F E @gatesfoundation.org Christa Bowles Executive Assistant Office of the President, Global Health V M E @gatesfoundation.org Bill & Melinda Gates Foundation www.gatesfoundation.org From: Conrad, Patricia (NIH/NIAID) [E] @niaid.nih.gov> Sent: Wednesday, April 15, 2020 9:34:23 AM To: Trevor Mundel @gatesfoundation.org> Cc: Lane, Cliff (NIH/NIAID) [E] @niaid.nih.gov>; Christa Bowles @gatesfoundation.org> Subject: on behalf of Dr. Fauci Per the call today with Mr. Gates - am adding Dr. Lane here so that you can connect and follow up. Please let me know if you need anything else from me - always happy to help. Best regards, Patricia L. Conrad Public Health Analyst and Special Assistant to the Director National Institute of Allergy and Infectious Diseases The National Institutes of Health 31 Center Drive, MSC 2520 - Room 7A03 Bethesda, Maryland 20892 fax Disclaimer: The information in this e-mail and any of its attachments is confidential and may contain sensitive information. It should not be used by anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete it from your mailbox or any other storage devices. National Institute of Allergy and Infectious Diseases (NIAID) shall not accept liability for any statement made that are sender's own and not expressly made on behalf of the NIAID by one of its representatives.